About
Bioatla Inc (NASDAQ:BCAB) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
BioAtla Announces Share Consolidation
Mar 31 2026
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mar 2 2026
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
Dec 31 2025
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Nov 21 2025
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing
Financials
Revenue
$2 M
Market Cap
$9.36 M
EPS
-50.50
Translate